Literature DB >> 6348567

IgA nephropathy: prognostic significance of proteinuria and histological alterations.

Y Kobayashi, S Tateno, Y Hiki, H Shigematsu.   

Abstract

A retrospective study of 166 patients with IgA nephropathy was undertaken to clarify possible correlations between clinical and histological features, and the severity and prognosis of the disease. At the time of biopsy, impaired renal function, with creatinine clearance (Ccr) below 90 ml/min was found in 61 cases. At the final examination, after a mean follow-up period of 34 months, 82 patients had impaired renal function, 12 of these patients went into terminal renal failure requiring hemodialysis treatment. The presence of proteinuria of more than 1.0 g/day was closely correlated with impairment of renal function both at the time of biopsy and at the final observation. An unfavorable outcome was also anticipated in the presence of hypertension. In contrast, microhematuria, macrohematuria or high serum IgA levels did not appear to be related to the outcome. Histologically, sclerotic lesions such as mesangial or global sclerosis, interstitial fibrosis and tubular atrophy, and some active changes such as mesangial hypercellularity and tuft adhesion were more frequent and severe in patients with impaired renal function. Impressive localization of IgA and C3 in the mesangium as well as in capillary loops was observed more often in these patients. These results clearly indicate that IgA nephropathy may follow a slowly progressive course in about half of the patients, and that marked proteinuria and severe histological changes appear to correlate closely with an unfavorable course.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348567     DOI: 10.1159/000183000

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  26 in total

1.  Long-term follow up of renal function in IgA nephropathy.

Authors:  U B Berg
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

2.  Renal histological changes in relation to renal function and urinary protein excretion in IgA nephropathy.

Authors:  U B Berg; S O Bohman; U Widstam-Attorps
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

Review 3.  Recognition and management of IgA nephropathy.

Authors:  L S Ibels; A Z Gyory; R J Caterson; C A Pollock; J F Mahony; D A Waugh; S Coulshed
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

4.  Screening for renal disease in school children: experience in Japan.

Authors:  T Kitagawa
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

5.  IgA nephropathy in adults: immunohistologic findings and clinical course.

Authors:  S K Parai; T Ghose
Journal:  Can Med Assoc J       Date:  1985-06-15       Impact factor: 8.262

6.  Treatment of severe IgA nephropathy in children.

Authors:  S P Andreoli; J M Bergstein
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3.

Authors:  H Kawachi; T Oite; F Shimizu
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  A molecular signature of proteinuria in glomerulonephritis.

Authors:  Heather N Reich; David Tritchler; Daniel C Cattran; Andrew M Herzenberg; Felix Eichinger; Anissa Boucherot; Anna Henger; Celine C Berthier; Viji Nair; Clemens D Cohen; James W Scholey; Matthias Kretzler
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

9.  Genetical, histological, and clinical characteristics of IgA-negative mesangioproliferative glomerulopathy.

Authors:  Kazunori Owada; Hodaka Suzuki; Tetsuo Katoh; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-11-25       Impact factor: 2.801

10.  Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.

Authors:  D J O'Donoghue; A Darvill; F W Ballardie
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.